Biosimilar Red Tape Elimination Act

Cost and committee reports

Official records Congress.gov attaches to H.R. 5526.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. PFLUGER, as printed in the Congressional Record (Vol. 171, No. 154, September 19, 2025, Page H4489):
  Article I Section 8 of the Unites States Constitution
  Source: Congress.gov, Congressional Record September 19, 2025 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  53 characters

  Congress.gov bill record

  H.R. 5526, 119th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/119/hr/5526

  Record last updated by Congress.gov

  July 22, 2026

  PORKER copy retrieved

  September 13, 2026

  Stored copy, SHA-256 of the file

  9be43f8b5b494d5183c2bdfd59deca3b0b6936de1f8919c790abc897bd09c510

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of July 22, 2026). Not every bill gets one.

From the Congress.gov bill record for H.R. 5526, last updated July 22, 2026. PORKER’s copy was retrieved September 13, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.